Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
Current assets:
Cash	$ 43,210	$ 17,256
Prepaid expenses, deposits, and other current assets	3,126	1,685
Total current assets	46,336	18,941
Other assets	1,035	837
Total assets	47,371	19,778
Current liabilities:
Accounts payable	3,766	2,966
Accrued expenses and other current liabilities	1,565	2,325
CARES Act Paycheck Protection Program note payable		300
Senior Secured Convertible Notes - at fair value		10,060
Senior Convertible Note - at fair value		4,600
Total liabilities	5,331	20,251
Commitments and contingencies (Note 5)
Stockholders’ Equity (Deficit):
Preferred stock, $0.001 par value. Authorized, 20,000,000 shares; Series B Convertible Preferred Stock, par value $0.001, issued and outstanding 1,185,685 at June 30, 2021 and 1,228,075 shares at December 31, 2020	2,499	2,537
Common stock, $0.001 par value. Authorized, 150,000,000 shares; 82,576,816 and 63,819,935 shares outstanding as of June 30, 2021 and December 31, 2020, respectively	83	64
Additional paid-in capital	149,694	87,570
Accumulated deficit	(109,325)	(88,275)
Total PAVmed Inc. Stockholders’ Equity	42,951	1,896
Noncontrolling interests	(911)	(2,369)
Total Stockholders’ Equity (Deficit)	$ 42,040	$ (473)